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ABSTRACT  
The U.S. military has a continued interest in the development of handheld, field-usable sensors and test kits for a variety 
of diagnostic applications, such as traumatic brain injury (TBI) and infectious diseases. Field-use presents unique 
challenges for biosensor design, both for the readout unit and for the biological assay platform. We have developed 
robust biosensor devices that offer ultra-high sensitivity and also meet field-use needs. The systems under development 
include a multiplexed quantitative lateral flow test strip for TBI diagnostics, a field test kit for the diagnosis of pathogens 
endemic to the Middle East, and a microfluidic assay platform with a label-free reader for performing complex 
biological automated assays in the field. 
Keywords: lateral flow immunoassay, dipstick assay, lateral flow test strip, field-based diagnostics, microfluidic chips, 
labelless detection, traumatic brain injury 
 
1. INTRODUCTION  
Advances in the fields of genomics and proteomics are offering a number of promising biomarkers that can aid in 
accurately predicting different diseases and health conditions. It is postulated that changes in the gene and protein 
expression levels can aid in the diagnosis of traumatic brain injury, the identification of chemical, biological or 
radiological exposures, organ damage, and failure of the immune system, and in the monitoring of physical stress and 
fatigue, epidemiological diseases, and other health conditions. To exploit the diagnostic potential of the biomarkers, it is 
necessary to build devices that can be used to assay these biomarkers in bodily fluids. Typically, multiple biomarkers 
need to be measured to accurately predict a particular health condition. Therefore, the diagnostic device must have the 
capability to detect/measure multiple biomarkers. In a clinical laboratory, complex automated instruments can be used to 
perform such assays. However, in a field setting, laboratory grade instruments are not appropriate because they: (1) are 
too complex to be useful for field use; (2) are too bulky to be carried; (3) require multiple steps to extract the sample and 
conduct tests; (4) require highly skilled personnel to run the instruments; (5) require labels to detect the biomarkers; (6) 
require multiple reagents to conduct the assays; and (7) are not reusable. Furthermore, many of these assays cannot 
withstand the conditions (temperature, humidity, etc.) present in the field. For all of these reasons, there is an immediate 
need to develop a simple, lightweight, handheld device that can be used in the field, by military personnel, for 
multiplexed detection of biomarkers. 
A field-usable diagnostic device to detect and measure biomarkers must meet the following requirements: (1) the assay 
developed for the biomarkers should preferably be reagent free, or utilize minimal amounts of reagents, to expeditiously 
and effectively conduct assays in the field without having to transport a number of reagents; (2) the device should 
detect/measure many biomarkers simultaneously in a single testing; (3) the device must be compact, lightweight, battery-
powered, and miniaturized for handheld testing by personnel; (4) the sample collection and processing steps must be 
simple and automated to be helpful for field use; (5) the software used to run the device must be simple, and must be 
able to store data from previous measurements so that the trends of different biomarkers can be compared for 
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longitudinal studies; and (6) since most of the biological elements are easily denatured by extremes of humidity and 
temperature, processes should be developed to stabilize the biological elements so that they can withstand these 
extremes. 
The lateral flow test strip is an attractive sensing format for field applications because the required reagents are present 
on the test strip, and the sample and reagents are transported, by capillary action, across the test strip, and therefore no 
pumps and valves are required. These attributes of the lateral flow test strip have popularized its use. The sensitivity of 
conventional test strips, however, is moderate, and the quantification of analytes and multiplexed measurements are 
difficult. The ability to measure multiple biomarkers quantifiably, at high sensitivity, on a single test strip, is necessary. 
An alternative technology that is attractive for field-based diagnostics would be a microfluidics assay platform. 
Microfluidics-based assays offer the promise of highly multiplexed measurements, precise control of sample volumes, 
and versatility in the manipulation of samples. Professor Axel Scherer’s group at Caltech has developed a multi-layer 
soft lithography-based miniaturized microfluidic chip that consists of hundreds of microfluidic channels, valves, and 
pumps to transport nanoliter volumes of samples to the sensing areas. The microfluidic chip design consists of patterned 
channels (control layer), above the microfluidics layer, that deflect air pressure to membranes that function as valves and 
pumps. We report on the utilization of inexpensive and high sensitivity cameras, and the recent availability of miniature 
pumps and solenoid valves that can be used to pressurize the control layer, to create a field-usable device that meets 
military needs. 
2. TECHNOLOGY 
2.1 Fieldable microfluidic assay readers 
The biomarker reader is designed, based on evanescent imaging ellipsometry,[1] to measure the effect that the binding of 
biomolecules to the microarray surface has on the polarization state of the reflected light. The polarization state of the 
light is defined by the phase and amplitude relationships between two components. The component having the electric 
field in the plane of incidence is known as the p-polarized light, and the component having the electric field normal to 
the plane of incidence is called the s-polarized light. In general, the reflection of light from an optical thin film causes a 
relative change in the phase and amplitude of the p and s polarized light. The change in phase difference between p and s 
components is characterized by the angle Δ, which is known as the retardance. The change in the amplitude ratio 
between p and s components is characterized by Tan(ψ). These definitions lead us to the fundamental equation of 
ellipsometry, 
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where rp and rs are the reflection coefficients for p-polarized light and s-polarized light, respectively. The change in the 
amplitude ratio between p and s components can also be characterized by diattenuation, which is defined as 
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A schematic diagram of the imaging ellipsometer is shown in Figure 1. In this configuration, the incident angle θ0 is 
larger than the critical angle required for Total Internal Reflection (TIR) from a glass prism surface in contact with a 
biomolecular film. The polarization state change is due to the TIR from the biomolecular film and the glass prism 
surface. If all the materials in the measurement sample are dielectric, only retardance Δ occurs at the TIR interface. Since 
the magnitude of the retardance Δ depends on the thickness and the refractive index of the film, the measurement of Δ 
will provide information about the optical parameters of the sample film. Furthermore, if absorbing materials are used in 
the sample diattenuation D will also couple into the measurement. 
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Figure 1 Principle of imaging ellipsometer microarray reader. Polarized light illuminates the microarray surface and is 
totally internally reflected. The changes in the retardance and diattenuation of the reflected beam are measured and related 
to the properties of the microarray surface. 
The measurement principles of the imaging ellipsometer can be fully explained with the help of Mueller matrix 
calculus.[2] Here, Jones matrix calculus is employed to provide a brief introduction of how the detection unit works. 
As shown in Figure 1, the incident monochromatic beam is collimated and transmitted through a linear polarizer and a 
linear retarder (quarter wave plate). The azimuthal orientations of the polarizer and the quarter wave plate determine the 
relative amplitudes and phase difference between the p and s components of the beam incident upon the substrate. These 
orientations are adjusted in such a way that the amplitudes of the p and s components are equal, and the difference in 
phase compensates for the retardance that results from the TIR from the hypotenuse surface of the glass prism. 
Therefore, the beam reflected off the glass-air interface is linearly polarized at 45° to the incident plane. It can be written 
in the form of a Jones vector as 
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This Jones vector is not normalized. It has a modulus of 0.5, because the polarizer only transmits half of the total power 
of the unpolarized incident beam. 
The reflected beam is then transmitted by an analyzer to a telephoto lens and a CCD array. The analyzer is oriented at 
135°. It can be written in terms of a Jones matrix as 
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If there were no sample film on the hypotenuse surface of the glass prism, in the ideal condition, the reflected beam 
would be completely extinguished by the analyzer, 
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However, by taking into account the retardance deviation Δ and diattenuation D introduced by the sample film on top of 
the glass surface, the left hand side of Equation 3-5 can be written in terms of the combination of two Jones matrices as 
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The beam reflected by the sample surface is not a linearly polarized beam. Its polarization state can be represented as 
Proc. of SPIE Vol. 8029  80290P-3
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 10/28/2016 Terms of Use: http://spiedigitallibrary.org/ss/termsofuse.aspx
 
 
 
 
01 0 11 1
0 12 20
s s
i i
p p
r r
e r r eΔ Δ
⎛ ⎞ ⎛ ⎞⎛ ⎞ ⎛ ⎞⋅ ⋅ =⎜ ⎟ ⎜ ⎟⎜ ⎟ ⎜ ⎟⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠⎝ ⎠ ⎝ ⎠   . (7) 
Therefore, the beam will not be completely extinguished by the analyzer oriented at 135°. The polarization state of the 
transmitted light can be represented as 
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After being transmitted by the analyzer oriented at 135°, the light is collected by a lens and forms an image of the sample 
surface on the CCD array. The intensity of the image can be written as 
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Since the thickness of the sample is much smaller than the optical wavelength (thickness of sample is less than 10 nm 
and the wavelength of incident light is 520 nm), we can use the following approximation to simplify the equation of the 
image intensity: 
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After the simplification, the image intensity can be written as 
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Therefore, in the microarray reader system, the relationship between (Δ, D) and the resulting image intensity Iout is given 
by:  
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In summary, spatial variations in Δ and D that occur due to the biomolecular layer result in the measured image intensity 
distribution. When the retardance deviation Δ and the diattenuation D introduced by the sample film are small, the image 
intensity Iout of the microarray reader is proportional to Δ2 + D2. Since the variation of Δ and D in the 2D space are 
associated with the spatial variations in thickness t or the refractive index n of the sample film, the image intensity can 
provide useful information about the optical parameters of the sample film. 
For a fully dielectric film, the contribution from diattenuation changes (D) is minimal and can be ignored. The intensity 
is then proportional to the square of the retardance changes. The calibration is based on the following calculations, where 
 I = c ⋅Δ2 . (13) 
For extremely thin thickness changes, the Drude approximation can be used. According to the Drude approximation,[3,4] 
the retardance deviation Δ is proportional to the thickness variation t of the extremely thin film. Thus, the calibration 
equation (Eq. 13) can be changed into: 
I = c ⋅t2 . 
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The prototype microfluidic biomarker reader developed at IOS represents a technological breakthrough in evanescent 
imaging ellipsometric approach. To our knowledge, there are no commercial devices that have a similar performance or 
form factor. Previous efforts by our collaborator, Professor Axel Scherer, involved the miniaturization of the 
microfluidic chips. However, air delivery to operate the embedded microfluidic pumps and valves, as well as fluid 
delivery to these chips, has been based on large, laboratory-based devices. We have successfully completed the 
development of a handheld system with self-contained units for the transport of all fluids within the portable 
microfluidic unit. This represents a technological and engineering breakthrough with applications in many different 
commercial markets (Figure 2). 
SECTION VIEW OF SYSTEM
FROM OPERATOR SIDE
INTERNAL  VIEW OF SYSTEM
FROM OPERATOR SIDE
 
(a) 
 
(b) 
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(c) 
Figure 2 Hardware/software developed under this contract was delivered to the U.S. Air Force: (a) labelless microfluidic 
evanescent field-usable imaging ellipsometry reader; (b) field-usable microfluidic system to transport reagents through the 
microfluidic chip; (c) microfluidic chips developed using soft lithography techniques. 
Soft lithography is a microfabrication technique in which a soft polymer such as PDMS is cast onto a mold containing a 
microfabricated relief. This technique has been used to create channels, valves, and pumps. This allows large-scale 
integration of microfluidic devices. Samples of nanoliter and picoliter volumes can be controlled with reproducibility 
and unprecedented control. 
The fabrication of the microfluidic sensor chips starts with a mold made in a silicon wafer – usually using 
photolithography. Next an elastomeric polymer, such as polydimethoxysilane (PDMS), is poured on top of the mold, and 
is then cured using UV. On curing, the elastomeric polymer layer is peeled off. This leaves an imprint of the mold 
topography on the surface of the polymer. Similarly, multiple layers of these elastomers with different patterns are 
bonded to each other to form a complete microfluidic device.  
A basic microfluidic chip contains two elastomer layers. One layer contains channels for flowing liquids (flow layer), 
and the other layer contains channels that when pressurized with air or nitrogen function as valves and pumps for the 
flow channels (control layer) as shown in Figure 2. Bonding of different layers is done thermally or using oxygen 
plasma. A slight difference between curing agent present in different layers is sufficient to allow two layers to bond.  
A microfluidic valve is created when two channels are cross-separated by a thin elastomeric membrane (Figure 3). The 
membrane is not shown explicitly in Figure 3. The space between the two channels is where the membrane is placed. In 
our approach, the flow layer of the chip is made very thin. This becomes the membrane (i.e., there will be a thin layer of 
PDMS above the channels in the flow layer). This thin layer separates the flow and control lines. The "d" in Figure 4 
represents the membrane thickness. When the control channel is pressurized with air, the thin membrane separating the 
two channels deflects into the flow channels creating a complete seal. 
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Figure 3 Fabrication of microfluidic channels using soft lithography. 
d
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Figure 4 Fabrication of valves (d = membrane thickness). 
Pressurizing one channel causes the membrane to deflect and block the other channel, creating a valve. A peristaltic 
pump is created when three valves in a row are operated in a sequence. This type of combination of valves and pumps 
can create fairly sophisticated circuits. These chips are extremely small (about one inch square), and can contain 
hundreds of valves and peristaltic pumps.  
2.2 Multiplexed quantitative lateral flow test strips 
Gold, silver, carbon, latex, colored dyes, enzymes, and fluorescent dyes have been used as labels in lateral flow test 
strips. Each of these labels possesses certain merits and some shortcomings. For example, latex particles easily 
agglutinate in the presence of binding components. However, in applications where the stability of the conjugate is 
critical to avoid false positives, the agglutination of latex particles can be a problem. Similarly, enzyme labels offer high 
sensitivity, however, enzymes sometimes produce an amorphous visual product, which may diffuse across the test strip, 
and render the results ambiguous. Enzyme labels can also suffer from stability problems.  
The advantages of gold labels include the ease of manufacturing uniform-sized particles and the ability to easily bind 
proteins to these particles. In addition, they also exhibit long-term stability in both liquid and dried forms. Gold labels 
have sensitivities comparable to enzyme-linked immunosorbent assay (ELISA). The main drawback of colloidal gold 
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particles is that quantifiable measurements are difficult. To address these problems, we utilized quantum dots as labels as 
part of the lateral flow test strip platform. Quantum dots are excited with a single light source (because QDs are excited 
with UV light at 365-390 nm), and emit spectrally in a narrow region. This results in significant improvement in the 
capabilities of the test strips, and reduces the cost of the reader.  
We have utilized quantum dot-based labeling technology to fabricate lateral flow test strips for the quantitative 
multiplexed detection of biomarkers from serum, urine, and other sample matrices. An optical test strip reader to 
measure, analyze, and archive the data has been developed. The reader is battery powered and can be used in doctors' 
offices, as well as for field-based applications. A photograph of the cassette reader and the test strip cassettes is shown in 
Figure 5. 
 
Figure 5 Quantum dot label-based lateral flow test strip reader. 
3. RESULTS 
3.1 Imaging ellipsometer assay platform testing 
To demonstrate the feasibility of detection, we selected the binding of IgG to Protein G as a model system. Epoxy 
derivatized microscope glass slides from Telechem International were purchased. Purified recombinant Protein G 
(Catalog # 21193) and Immunopure goat anti-mouse IgG (H+L) (Catalog # 31160) were purchased from Pierce 
Biotechnology Inc (Rockford, IL). Protein G, Bovine Serum Albumin (BSA) and goat anti-mouse IgG were spotted on 
an epoxy derivatized microscope glass slide using a microspotter. The proteins were spotted as four separate grids. Each 
grid has six rows and eight spots in each row. Protein G was spotted on the first and second rows, the third and fourth 
rows were spotted with BSA, and the fifth and sixth rows contained goat anti-mouse IgG. BSA and goat anti-mouse IgG 
function as negative controls. The binding to the Protein G spots were studied.  
The prepared arrays were washed three times with PBS buffer, and were blocked with 1% BSA in PBS buffer. The array 
was placed over the prototype reader and a retardance image of the array was taken. The retardance image was 
calculated using mini-ellipsometer LabVIEW software. Two images (at +5° and -5° analyzer position) were taken. These 
two images were used to calculate the retardance of the array (Figure 6a). Next, the microarray was incubated with goat 
anti-mouse IgG for ten minutes. The sample was washed in PBS buffer, and the retardance image was then taken (Figure 
6b). The surface plots of the same images are shown in Figures 7a and 7b, respectively. 
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Figure 6 Retardance images of the biochip taken by the benchtop prototype: (a) before binding; and (b) after binding goat 
anti-mouse IgG. 
 
Figure 7 Surface plots of retardance images taken using the prototype reader: (a) before binding; and (b) after binding goat 
anti-mouse IgG. 
For a validation experiment, the microarray was incubated with Hilyte Fluor™ 647 labeled goat anti-mouse IgG, and 
was washed with PBS. The fluorescence intensities from the spots were measured with a fluorescent scanner (Figure 8). 
 
Figure 8 The fluorescent image of the microarray used for validation experiments. The first rows that contain Protein G 
bind strongly to fluorescent labeled goat anti-mouse IgG. 
3.2 TBI diagnosis 
One in every four combat casualties is due to battlefield head injuries. Clinically, head injuries result in cognitive 
deficits, and in impaired memory, judgment, and perception. The closed head injuries caused by impacts from 
improvised explosive devices (IEDs) and rocket propelled grenades are a major concern, because they are difficult to 
detect. The early detection of these head injuries in battlefield settings is critical to improving the treatment and therapy 
of injured personnel. Additionally, the detection device must be simple to use; the test must be based on easy to collect 
samples (e.g., blood, serum, urine, or saliva); and the test must be sensitive and specific. Recent studies have resulted in 
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the discovery of several promising biomarkers, such as S100B, isoprostane, glial fibrillary acidic protein (GFAP), and 
neuron specific enolase (NSE), that could be useful in diagnosing brain injury.  
Starting from 10 hours, serum samples were collected every 12 hours until 136 hours after TBI insult, from adult TBI 
patients (n = 20, age 21-74 years) with a Glasgow Coma Scale score ≤ 8. Biomarkers were measured and the results 
showed that S100B, NSE, and GFAP were elevated in TBI patients, and reached peak concentrations at 40 h, 50 h, and 
40 h after injury, respectively. The GFAP levels reached base line values by 64 h after injury. A 2.64, 12.8, and 56.3 fold 
increase in NSE, S100B and GFAP respectively were observed between TBI and controls. F2-isoprostane was not 
significantly increased in TBI patients. More tests and data analysis are underway to relate the biomarkers to the severity 
and outcome of TBI by using patients with mild/moderate TBI and patients with peripheral injuries as controls. 
 
Figure 9 Time course of measured TBI biomarkers in patients. Results show a strong elevation in the concentrations of 
S100B, NSE and GFAP in TBI patients. 
4. CONCLUSIONS 
Fieldable biomarker detection technologies can have a significant impact on field medicine, and can lead to the timely 
and accurate diagnosis of conditions such as traumatic brain injury. Both the lateral flow technology and the microfluidic 
technology can be adapted to achieve robust and accurate devices. The clinical data suggests that protein-based 
biomarkers are elevated after TBI, and can be used to develop a diagnostic tool. 
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